Cost analysis of an integrated disease surveillance and response system : case of Burkina Faso , Eritrea , and Mali

Background: Communicable diseases are the leading causes of illness, deaths, and disability in sub-Saharan Africa. To address these threats, countries within the World Health Organization (WHO) African region adopted a regional strategy called Integrated Disease Surveillance and Response (IDSR). This strategy calls for streamlining resources, tools, and approaches to better detect and respond to the region's priority communicable disease. The purpose of this study was to analyze the incremental costs of establishing and subsequently operating activities for detection and response to the priority diseases under the IDSR. Methods: We collected cost data for IDSR activities at central, regional, district, and primary health care center levels from Burkina Faso, Eritrea, and Mali, countries where IDSR is being fully implemented. These cost data included personnel, transportation items, office consumable goods, media campaigns, laboratory and response materials and supplies, and annual depreciation of buildings, equipment, and vehicles. Results: Over the period studied (2002–2005), the average cost to implement the IDSR program in Eritrea was $0.16 per capita, $0.04 in Burkina Faso and $0.02 in Mali. In each country, the mean annual cost of IDSR was dependent on the health structure level, ranging from $35,899 to $69,920 at the region level, $10,790 to $13,941 at the district level, and $1,181 to $1,240 at the primary health care center level. The proportions spent on each IDSR activity varied due to demand for special items (e.g., equipment, supplies, drugs and vaccines), service availability, distance, and the epidemiological profile of the country. Conclusion: This study demonstrates that the IDSR strategy can be considered a low cost public health system although the benefits have yet to be quantified. These data can also be used in future studies of the costeffectiveness of IDSR. Published: 8 January 2009 Cost Effectiveness and Resource Allocation 2009, 7:1 doi:10.1186/1478-7547-7-1 Received: 16 June 2008 Accepted: 8 January 2009 This article is available from: http://www.resource-allocation.com/content/7/1/1 © 2009 Somda et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

[1]  S. Thacker,et al.  Planning an integrated disease surveillance and response system: a matrix of skills and activities , 2007, BMC medicine.

[2]  Alan D. Lopez,et al.  Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data , 2006, The Lancet.

[3]  D. Evans,et al.  Cost effectiveness analysis of strategies to combat malaria in developing countries , 2005, BMJ : British Medical Journal.

[4]  J. Fox-Rushby,et al.  The effects and costs of expanding the coverage of immunisation services in developing countries: a systematic literature review. , 2005, Vaccine.

[5]  Julia Fox-Rushby,et al.  Cost of delivering child immunization services in urban Bangladesh: a study based on facility-level surveys. , 2004, Journal of health, population, and nutrition.

[6]  A. Uzicanin,et al.  Economic analysis of the 1996-1997 mass measles immunization campaigns in South Africa. , 2004, Vaccine.

[7]  Steven Russell,et al.  The economic burden of illness for households in developing countries: a review of studies focusing on malaria, tuberculosis, and human immunodeficiency virus/acquired immunodeficiency syndrome. , 2004, The American journal of tropical medicine and hygiene.

[8]  P. Strebel,et al.  Cost-effectiveness of three different vaccination strategies against measles in Zambian children. , 2004, Vaccine.

[9]  J. Sachs,et al.  The economic and social burden of malaria , 2002, Nature.

[10]  B. Perkins,et al.  Technical guidelines for integrated disease surveillance and response in the African region , 2001 .

[11]  B. Gessner,et al.  Comparison of cost-effectiveness of preventive and reactive mass immunization campaigns against meningococcal meningitis in West Africa: a theoretical modeling analysis. , 2001, Vaccine.

[12]  D. Evans,et al.  Critical issues in the economic evaluation of interventions against communicable diseases. , 2001, Acta tropica.

[13]  J. Fox-Rushby,et al.  Economic evaluation of communicable disease interventions in developing countries: a critical review of the published literature. , 2000, Health economics.

[14]  M. Meltzer,et al.  Costs and benefits of a subtype-specific surveillance system for identifying Escherichia coli O157:H7 outbreaks. , 2000, Emerging infectious diseases.

[15]  V. Balraj,et al.  Disease surveillance at district level: a model for developing countries , 1998, The Lancet.

[16]  J. Barendregt,et al.  Global burden of disease , 1997, The Lancet.

[17]  함일한,et al.  Surveillance , 1996 .

[18]  Anne Mills,et al.  The economic impact of malaria in Africa: a critical review of the evidence. , 2003, Health policy.

[19]  K. Barnes,et al.  An economic comparison of chloroquine and sulfadoxine-pyrimethamine as first-line treatment for malaria in South Africa: development of a model for estimating recurrent direct costs. , 2002, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[20]  N. Ndayimirije,et al.  Structure and performance of infectious disease surveillance and response, United Republic of Tanzania, 1998. , 2002, Bulletin of the World Health Organization.

[21]  P. Jha,et al.  The cost-effectiveness of forty health interventions in Guinea. , 1998, Health policy and planning.